This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Meridian Medical Technologies, a Kindeva Drug Delivery company, will be expanding its manufacturing capabilities in Bridgeton, Mo., investing more than $100 million over the next four years in a newly purchased facility. The company will be converting the 155,000-sq-ft facility to support increased production of drug-device combination products and sterile fill-finish capabilities, and create job opportunities in the St. Louis area.
Meridian founded the autoinjector technology and has been a leading manufacturer of emergency autoinjectors for more than 60 years. Now a part of Kindeva, the combined company has a broader range of drug delivery capabilities that this Bridgeton facility investment will help support worldwide.
“Meridian brings a strong history of specific expertise to support critical manufacturing capabilities for complex products—addressing a manufacturing shortage we have seen increase over the last several years,” says Milton Boyer, Meridian CEO. “Building a broader platform with the latest technologies and equipment available, coupled with enhanced capabilities in the production of pre-filled syringes and cartridges, will enable Meridian to offer a broader array of CDMO services and increased capacity to our customers.”
Since January 2022, Meridian has added approximately 300 employees for a total of approximately 900 in the St. Louis area. The company’s new facility, which will be completed in 2024, will support continued growth by dramatically increasing its abilities to develop and manufacture products that will bring new medicines to new markets and customers worldwide.
For the expansion, Meridian will benefit from the Missouri Works program, a tool that helps companies expand and retain workers by providing access to capital through withholdings or tax credits for job creation.
